Flora Growth (FLGC) Stock Price, News & Analysis

Company Overview

Flora Growth Corp (NASDAQ: FLGC) is a vertically integrated cannabis and hemp company engaged in the cultivation, extraction, formulation and distribution of cannabinoid-based products. Its portfolio encompasses a broad range of offerings, including oils, vape cartridges, edibles, topicals and patent-pending delivery systems designed for both medical and wellness applications.

Founded in 2018, Flora Growth has established cultivation and processing operations in Uruguay’s greenhouse hubs, complemented by extraction and formulation laboratories in Florida. This geographic footprint enables the company to supply regulated markets across the Americas and to explore select opportunities in Europe and Latin America through both branded and private-label channels.

The company places a strong emphasis on research and development, with a multidisciplinary team dedicated to advancing nanoemulsion technologies, transdermal patches and other novel delivery methods. These R&D efforts aim to improve product efficacy in areas such as pain management, dermatology and general wellness, while complying with evolving regulatory standards.

Headquartered in Vancouver, British Columbia, with regional offices in Montevideo and Miami, Flora Growth is led by Chairman and CEO Richard Pattison. Under his guidance, the management team leverages deep expertise in agronomy, bioprocessing and international business development to navigate complex market dynamics and drive long-term growth.

Key Stats

• Today's Range: $17.77 to $19.75
• 50-Day Range: $17.27 to $33.51
• 52-Week Range: $15.15 to $82.29
• Volume: 34,687 shs
• Average Volume: 107,483 shs
• Market Capitalization: $12.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $93.00
• Consensus Rating: Hold

Flora Growth Stock Analysis - MarketRank™

Flora Growth scored higher than 46% of companies evaluated by MarketBeat, and ranked 620th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Hold

Consensus Rating

Flora Growth has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Flora Growth has a consensus price target of $93.00, representing about 414.7% upside from its current price of $18.07.

Amount of Analyst Coverage

Flora Growth has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Flora Growth are expected to grow in the coming year, from ($0.93) to ($0.18) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Flora Growth is -0.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Flora Growth is -0.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Flora Growth has a P/B Ratio of 1.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.76% of the float of Flora Growth has been sold short.

Short Interest Ratio / Days to Cover

Flora Growth has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Flora Growth has recently increased by 69.70%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Flora Growth does not currently pay a dividend.

Dividend Growth

Flora Growth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.76% of the float of Flora Growth has been sold short.

Short Interest Ratio / Days to Cover

Flora Growth has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Flora Growth has recently increased by 69.70%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: N/A

News Sentiment

Flora Growth has a news sentiment score of -0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Flora Growth this week, compared to 1 article on an average week.

Search Interest

2 people have searched for FLGC on MarketBeat in the last 30 days.

MarketBeat Follows

3 people have added Flora Growth to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Flora Growth insiders have not sold or bought any company stock.

Percentage Held by Insiders

12.56% of the stock of Flora Growth is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 36.01% of the stock of Flora Growth is held by institutions.

FLGC Stock Analysis - Frequently Asked Questions

How have FLGC shares performed this year?

Flora Growth's stock was trading at $40.17 on January 1st, 2025. Since then, FLGC shares have decreased by 55.0% and is now trading at $18.07.

How were Flora Growth's earnings last quarter?

Flora Growth Corp. (NASDAQ:FLGC) posted its quarterly earnings results on Friday, August, 1st. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.05. The company earned $14.80 million during the quarter, compared to analyst estimates of $11.77 million. Flora Growth had a negative trailing twelve-month return on equity of 261.57% and a negative net margin of 24.86%.

When did Flora Growth's stock split?

Flora Growth's stock reverse split before market open on Friday, June 9th 2023.The 1-20 reverse split was announced on Friday, June 9th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 9th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Flora Growth IPO?

Flora Growth (FLGC) raised $15 million in an IPO on Tuesday, May 11th 2021. The company issued 3,300,000 shares at $4.00-$5.00 per share. Boustead Securities acted as the underwriter for the IPO.

How do I buy shares of Flora Growth?

Shares of FLGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Flora Growth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Flora Growth investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Tesla (TSLA), NIO (NIO) and

Company Calendar

• Last Earnings: 8/01/2025
• Today: 10/07/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:FLGC
• CIK: 1790169
• Web: floragrowth.ca
• Phone: 954-842-4989
• Fax: N/A
• Employees: 280
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Flora Growth: $93.00
• High Price Target: $156.00
• Low Price Target: $30.00
• Potential Upside/Downside: +386.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($34.38)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$15.91 million
• Net Margins: -24.86%
• Pretax Margin: -25.44%
• Return on Equity: -261.57%
• Return on Assets: -48.06%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 0.96
• Quick Ratio: 0.61

Sales & Book Value

• Annual Sales: $59.51 million
• Price / Sales: 0.23
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $12.21 per share
• Price / Book: 1.57

Miscellaneous

• Outstanding Shares: 710,000
• Free Float: 623,000
• Market Cap: $13.58 million
• Optionable: Not Optionable
• Beta: 1.93